Latham Leads Kailera's $625M IPO In Obesity Drug Push
By Yeji Jesse Lee · April 17, 2026, 4:25 PM EDT
Obesity biotech Kailera Therapeutics made its public debut Friday, raising $625 million in an upsized initial public offering that represents one of the largest biotech IPOs in recent years....
To view the full article, register now.
Try a seven day FREE Trial
Already a subscriber? Click here to login